Clinical trials
Observational Insulin Resistance trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 3 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Unknown status | 6 |
| Recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Catholic University of the Sacred Heart | 2 |
| Universita di Verona | 2 |
| Azienda Ospedaliero, Universitaria Pisana | 1 |
| Comune di Napoli | 1 |
| Eli Lilly and Company | 1 |
| Federico II University | 1 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 1 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | 1 |
| Fondazione Toscana Gabriele Monasterio | 1 |
| Istituto Auxologico Italiano | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insulin Resistance | 21 |
| Diabetes Mellitus, Type 2 | 5 |
| Diabetes Mellitus | 4 |
| Obesity | 4 |
| Cardiovascular Diseases | 2 |
| Hyperinsulinism | 2 |
| Hypoglycemia | 2 |
| Inflammation | 2 |
| Metabolic Syndrome | 2 |
| Obesity, Morbid | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.